GlaxoSmithKline PLC (GSK) — Long-term Investment Intensity
GlaxoSmithKline PLC (GSK) has a Long-term Investment Intensity of 2.7% as of December 2019. Long-term investments of GBX2.16 Billion represent 2.7% of total assets of GBX79.69 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check GlaxoSmithKline PLC asset resilience ratio to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
GlaxoSmithKline PLC Long-term Investment Intensity (2013–2019)
This chart shows how GlaxoSmithKline PLC's Long-term Investment Intensity has evolved across 7 annual periods from 2013 to 2019. As of December 2019, the intensity stands at 2.7%, reflecting long-term investments of GBX2.16 Billion against total assets of GBX79.69 Billion GBX. For the complete balance sheet picture, see GlaxoSmithKline PLC total assets.
Annual Long-term Investment Intensity for GlaxoSmithKline PLC (2013–2019)
The table below presents the year-by-year Long-term Investment Intensity for GlaxoSmithKline PLC from 2013 to 2019, covering 7 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read GSK current and long-term liabilities for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (GBX) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2019 | 2.7% | GBX2.16 Billion | GBX79.69 Billion | ▲ +0.0 pp |
| 2018 | 2.7% | GBX1.56 Billion | GBX58.07 Billion | ▲ +0.7 pp |
| 2017 | 2.0% | GBX1.11 Billion | GBX56.38 Billion | ▼ -0.1 pp |
| 2016 | 2.1% | GBX1.25 Billion | GBX59.08 Billion | ▼ -0.6 pp |
| 2015 | 2.7% | GBX1.46 Billion | GBX53.45 Billion | ▼ -0.8 pp |
| 2014 | 3.6% | GBX1.45 Billion | GBX40.65 Billion | ▼ 0.0 pp |
| 2013 | 3.6% | GBX1.53 Billion | GBX42.09 Billion | — |